TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunityMyrofora Panagi, Triantafyllos Stylianopoulos, Chrysovalantis Voutouri et al.|Theranostics|2020Cited by 200
Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer modelsMyrofora Panagi, Triantafyllos Stylianopoulos, Yasuhiro Nakagawa et al.|Nature Communications|2022Cited by 109
Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung MetastasisFotios Mpekris, Triantafyllos Stylianopoulos, Myrofora Panagi et al.|Advanced Science|2020Cited by 106
The Role of Tumor-Associated Myeloid Cells in Modulating Cancer TherapyChristiana M. Neophytou, Panagiotis Papageorgis, Chryso Pierides et al.|Frontiers in Oncology|2020Cited by 78
Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosisJufang Chi, Paul Costeas, K A Nicolaou et al.|Leukemia|2013Cited by 57